| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |